CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes Industry Satellite Symposia

Medical need to improve on standard therapies for HR+/HER2- EBC (ID 334)

Lecture Time
19:00 - 19:05
Speakers
  • J. Cortes Castan (Barcelona, Spain)
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00